View printer-friendly version |
Charles River Laboratories Appoints John Crowley as Corporate Senior Vice President, Corporate Controller and Chief Accounting Officer
Immediately prior to joining Charles River, Mr. Crowley was Vice
President, Chief Accounting Officer & Corporate Controller of
Mr. Crowley commented, “Charles River has a compelling value proposition and a unique business model. I look forward to playing an integral role in its future growth and success.”
Mr. Crowley holds a B.S. in both Economics and Accountancy from
Caution Concerning Forward-Looking Statements
This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may be identified by the use of words such as
“anticipate,” “believe,” “expect,” “will,” “may,” “estimate,” “plan,”
“outlook,” and “project” and other similar expressions that predict or
indicate future events or trends or that are not statements of
historical matters. Forward-looking statements are based on Charles
River’s current expectations and beliefs, and involve a number of risks
and uncertainties that are difficult to predict and that could cause
actual results to differ materially from those stated or implied by the
forward-looking statements. A description of these risks, uncertainties,
and other matters can be found in the Risk Factors detailed in Charles
River's Annual Report on Form 10-K as filed on
About
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com
Source:
Investors:
Charles River Laboratories
Susan E. Hardy,
781-222-6190
Corporate Vice President, Investor Relations
susan.hardy@crl.com
or
Media:
Charles
River Laboratories
Amy Cianciaruso, 781-222-6168
Executive
Director of Public Relations and Corporate Communications
amy.cianciaruso@crl.com